XKEM aktuel empfohlen unter:

ich glaube dies wolltest du:
LATEST:

Last Updated: 23rd June


March 3rd, 2006
Obasanjo to launch locally produced sickle cell drug
E-MAIL THIS PRINT THIS Most Viewed



President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country\'s population.

Isoun spoke at the inaugural meeting of the Ministers’ Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation’s targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria’s collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."

 

Danke.
Das ist schon witzig, wenn zwei Threads zu einem Wert parallel laufen. Man ist gezwungen dauernd hin und her zu springen. :-)

Ich muss jetzt los. Mein Hund wartet schon lange: will seine Runde laufen.

Pass schön auf auf das Baby X. Ich schaue später noch rein.

lg
o

 

nicht mehr gegen 10 cent - aber wenn wir bei 6 cent schliessen ist das auch eine gute basis für die naechste woche!  

jetzt geht es richtig los. In der Erwartung von News wird wohl keiner ins Wochenende gehen, ohne sich eingedeckt zu haben.

Beachtungsvoll sind die Gegenströme der MMs. Das ist doch ein Wahnsinn, wie die an die SLs ran wollen.

Na ja, wir haben diesen schwierigen Tag beinah hinter uns.

Wann kommen wohl die Nachrichten?...

lg
o  

Na gut, immerhin im Grünen.

Wir hören von einander spätestens am Mo.

Wünscht mir Glück für VWL-Klausur morgen.

Ein schönes Wochenende
o  

http://www.stockhouse.com/news/news.asp?newsid=3973853&tick=XKEM

oder auch hier:
Xechem International, Inc. (OTCBB: XKEM - http://finance.yahoo.com/q?s=XKEM.OB)

Xechem International, Inc. announced that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Drug Products Development, for the five-membered heterocyclic anti-sickling compound known as 5-HMF for the treatment of patients suffering from sickle cell disease (SCD).

Research led by Dr. Donald Abraham of Virginia Commonwealth University (VCU) has shown 5-HMF to be "the best potential anti-sickling agent in 30 years of sickle cell research", performed by his group. 5-HMF not only is a natural product with very little, if any, toxicity, but it has a high affinity for sickle cell hemoglobin. It is also very active in genetically modified mice as shown by Dr. Toshio Asakura, Director, and his colleagues at the NIH-NHLBI Sickle Cell Disease Reference Laboratory at the Children's Hospital of Philadelphia, University of Pennsylvania.

According to Xechem's Chairman and CEO, Dr. Ramesh Pandey, "We are pleased with the FDA's decision granting Orphan Drug Designation to 5-HMF. This puts Xechem into a unique position where the company will have two drugs in the pipeline for treating patients with sickle cell disease. 5-HMF is a new type of drug that interacts specifically with intracellular hemoglobin without interacting with other proteins in the body. Today there are no non-toxic drugs available on the market to treat SCD. We are actively proceeding with our first drug (NICOSAN(TM)) in the hope of bringing it to the Nigerian market immediately following Nigerian regulatory approval. We are also preparing the Investigational New Drug (IND) application for 5-HMF for submission to the FDA in the coming months."

dieser artikel ist gestern nachbörslich erschienen  

wo eröffnen die amis?

wenn sie sich an folgende kursziele halten:

http://www.southendstockpickers.com/

gibts wohl einen kraeftigen gap up!  

Sind euch der Artikel schon bekannt? Ich stelle den nur vorsichtshalber rein. Vielleicht hätte da jemand Interesse daran:

http://test.investor.reuters.com/business/...scompfake%2fbuscompdescr

lg
o

 

moin!
es kann grundsaetzlich nicht schaden wenn du infos reinstellst! schliesslich ist viellecht nicht jeder über diesen rohdiamanten so gut informiert wie wir, und deshalb ist es nur gut wenn auch andere user nachhaltig informiert werden! schliesslich waere es schade wenn sich irgendjemand die chance entgehen lassen würde...  

Hallo,

bin neu und habe mit Interesse die diversen Aussagen ueber die "Shorties" gelesen, sehr interessant und vielen Dank.

Eine sehr dumme Frage bzgl. der Verkaufsorder:
Wie muss ich jene eingeben - unter Stop / Loss.  

habe ich gefunden:

http://www.cometnewsonline.com/capital.html

Stichwort: Kapitalverdopplung

lg
o  

bei welcher Bank bist du?  

diba, DB und in Kuerze flatex  

 

Sorry, was meinst du mit BM. danke  

 

Oben, wo "Willkommen, Zeppelin" ist eine gelbe Markierung mit 1 BM drinne. Klick mal genau darauf - du bekommst ein BoardMail  

Wie gesagt, bin neu - wo kann ich die Board mail nachschauen. Sorry, to bother you mit solchen nichtsagenden Problemen.  

es geht weiter nördlich!  

Ist vielleicht nicht heute mein Tag. sehe ich ein "Willkommen, Zeppelin" noch eine Boardmail. Danke!!!!  

du L2 zu sehen? Interessante Zahlen:

Symbol: For Real-Time click here!

Symbol: XKEM

L2 Summary
Bid Level #MM's Size Ask Level #MM's Size
0.0705 1 50 0.0710 2 100
0.0700 1 50 0.0711 1 50
0.0690 1 50 0.0720 1 450
0.0680 2 100 0.0730 3 150

L2 Quote:
MM on Bid : 33
MM on Ask : 34
MM ID Bid Size Time
UBSS 0.0705 50 10:48:55
NITE 0.0700 50 10:48:09
HDSN 0.0690 50 10:42:59
TDCM 0.0680 50 10:21:20
AUTO 0.0680 50 10:49:40
VFIN 0.0675 50 10:24:40
VIEW 0.0671 50 09:33:38
MAXM 0.0670 50 09:54:59
JEFF 0.0670 50 10:00:16
FRAN 0.0650 50 09:22:08
CLYP 0.0650 50 09:55:03
QUIN 0.0650 50 09:55:33
HILL 0.0650 50 10:45:28
MM ID Ask Size Time
NITE 0.0710 50 10:48:09
UBSS 0.0710 50 10:48:55
ARCA 0.0711 50 10:41:00
SBSH 0.0720 450 10:39:25
ETRD 0.0730 50 10:34:40
GROW 0.0730 50 10:49:03
AUTO 0.0730 50 10:49:40
VERT 0.0740 50 10:31:04
HDSN 0.0740 50 10:42:59
JEFF 0.0745 50 10:00:16
CLYP 0.0750 50 09:55:03
TDCM 0.0750 50 10:21:20
HILL 0.0750 50 10:45:28  

Symbol: XKEM

L2 Summary
Bid Level #MM's Size  Ask Level #MM's Size
0.0671 2 100  0.0002 13 15050000
0.0670 4 200  0.0003 3 15000
0.0650 6 300  0.0690 4 200
0.0630 4 200  0.0695 2 100

L2 Quote:
MM on Bid : 66  
MM on Ask : 84
MM ID Bid Size Time  
UBSS 0.0671 50 12:04:37  
UBSS 0.0671 50 12:04:37  
NITE 0.0670 50 12:01:42  
NITE 0.0670 50 12:01:42  
HDSN 0.0670 50 12:02:33  
HDSN 0.0670 50 12:02:33  
HILL 0.0650 50 11:35:59  
HILL 0.0650 50 11:35:59  
TDCM 0.0650 50 11:51:53  
TDCM 0.0650 50 11:51:53  
MAXM 0.0650 50 11:55:57  
MAXM 0.0650 50 11:55:57  
JEFF 0.0630 50 11:27:01  
MM ID Ask Size Time
ETRD 0.0002 9000000 11:45:19
HDSN 0.0002 5000 11:45:19
HILL 0.0002 5000 11:45:19
JEFF 0.0002 5000 11:45:19
MAXM 0.0002 5000 11:45:19
NITE 0.0002 5000 11:45:19
STGI 0.0002 5000 11:45:20
TASL 0.0002 1000000 11:45:20
TDCM 0.0002 5000 11:45:20
UBSS 0.0002 5000 11:45:20
VERT 0.0002 5000 11:45:20
VFIN 0.0002 5000 11:45:20
WDCO 0.0002 5000000 11:50:15


 

 

mit xkem?  

gibt es kein halt mehr, für xkem ..